Biotech

All Articles

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its numerous sclerosis (MS) med tolebrutinib to the FDA, exe...

Galapagos' stock up as fund presents intent to mold its own development

.Galapagos is happening under additional stress coming from financiers. Having actually constructed ...

Cell- centered Sana gathers first CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable management hirings, firings and al...

Allist pays Jacobio $21M, landing function in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has actually purchased itself a starring character in China's KRAS ...

ReNeuron leaving behind goal swap after overlooking fundraising goal

.ReNeuron has joined the lengthy listing of biotechs to leave behind London's goal securities market...

MBX declare IPO to take challenger to Ascendis into stage 3

.MBX Biosciences has actually included in the recent spurt of IPO filings. The biotech, which submit...

FDA broadens probing into Lykos' MDMA tests: WSJ

.For Lykos Rehabs and also the firm's prospective MDMA-assisted treatment for post-traumatic stress ...

Gene publisher Volume laying off 131 employees

.Simply days after genetics publisher Volume Biosciences introduced secret operational slices, a mor...

Repare lays off 25% of team as biotech stops preclinical R&ampD

.Repare Therapeutics is actually laying off a quarter of its own labor force as the oncology biotech...

J &amp J files for FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually gotten one more step toward recognizing a gain on its own $6.5 bi...